Literature DB >> 35674905

Functional Studies of Genetic Variants Associated with Human Diseases in Notch Signaling-Related Genes Using Drosophila.

Sheng-An Yang1,2, Jose L Salazar1,2, David Li-Kroeger3,4, Shinya Yamamoto5,6,7,8.   

Abstract

Rare variants in the many genes related to Notch signaling cause diverse Mendelian diseases that affect myriad organ systems. In addition, genome- and exome-wide association studies have linked common and rare variants in Notch-related genes to common diseases and phenotypic traits. Moreover, somatic mutations in these genes have been observed in many types of cancer, some of which are classified as oncogenic and others as tumor suppressive. While functional characterization of some of these variants has been performed through experimental studies, the number of "variants of unknown significance" identified in patients with diverse conditions keeps increasing as high-throughput sequencing technologies become more commonly used in the clinic. Furthermore, as disease gene discovery efforts identify rare variants in human genes that have yet to be linked to a disease, the demand for functional characterization of variants in these "genes of unknown significance" continues to increase. In this chapter, we describe a workflow to functionally characterize a rare variant in a Notch signaling related gene that was found to be associated with late-onset Alzheimer's disease. This pipeline involves informatic analysis of the variant of interest using diverse human and model organism databases, followed by in vivo experiments in the fruit fly Drosophila melanogaster. The protocol described here can be used to study variants that affect amino acids that are not conserved between human and fly. By "humanizing" the almondex gene in Drosophila with mutant alleles and heterologous genomic rescue constructs, a missense variant in TM2D3 (TM2 Domain Containing 3) was shown to be functionally damaging. This, and similar approaches, greatly facilitate functional interpretations of genetic variants in the human genome and propel personalized medicine.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Alzheimer’s disease; Drosophila melanogaster; Functional genomics; Genome-wide association studies (GWAS); Notch signaling; TM2D3; Variant of unknown significance (VUS); Whole-exome sequencing (WES); Whole-genome sequencing (WGS); almondex

Mesh:

Year:  2022        PMID: 35674905      PMCID: PMC9396741          DOI: 10.1007/978-1-0716-2201-8_19

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  123 in total

Review 1.  Notch and disease: a growing field.

Authors:  Angeliki Louvi; Spyros Artavanis-Tsakonas
Journal:  Semin Cell Dev Biol       Date:  2012-02-20       Impact factor: 7.727

Review 2.  Adams-Oliver syndrome review of the literature: Refining the diagnostic phenotype.

Authors:  Susan Hassed; Shibo Li; John Mulvihill; Christopher Aston; Susan Palmer
Journal:  Am J Med Genet A       Date:  2017-02-04       Impact factor: 2.802

3.  P[acman]: a BAC transgenic platform for targeted insertion of large DNA fragments in D. melanogaster.

Authors:  Koen J T Venken; Yuchun He; Roger A Hoskins; Hugo J Bellen
Journal:  Science       Date:  2006-11-30       Impact factor: 47.728

4.  Monitoring Notch activity in the mouse.

Authors:  Swananda Marathe; Lavinia Alberi
Journal:  Methods Mol Biol       Date:  2014

Review 5.  The Varied Roles of Notch in Cancer.

Authors:  Jon C Aster; Warren S Pear; Stephen C Blacklow
Journal:  Annu Rev Pathol       Date:  2016-12-05       Impact factor: 23.472

6.  A genome-wide resource for the analysis of protein localisation in Drosophila.

Authors:  Mihail Sarov; Christiane Barz; Helena Jambor; Marco Y Hein; Christopher Schmied; Dana Suchold; Bettina Stender; Stephan Janosch; Vinay Vikas K J; R T Krishnan; Aishwarya Krishnamoorthy; Irene R S Ferreira; Radoslaw K Ejsmont; Katja Finkl; Susanne Hasse; Philipp Kämpfer; Nicole Plewka; Elisabeth Vinis; Siegfried Schloissnig; Elisabeth Knust; Volker Hartenstein; Matthias Mann; Mani Ramaswami; K VijayRaghavan; Pavel Tomancak; Frank Schnorrer
Journal:  Elife       Date:  2016-02-20       Impact factor: 8.140

7.  Evaluation of in silico algorithms for use with ACMG/AMP clinical variant interpretation guidelines.

Authors:  Rajarshi Ghosh; Ninad Oak; Sharon E Plon
Journal:  Genome Biol       Date:  2017-11-28       Impact factor: 13.583

Review 8.  Model Organisms Facilitate Rare Disease Diagnosis and Therapeutic Research.

Authors:  Michael F Wangler; Shinya Yamamoto; Hsiao-Tuan Chao; Jennifer E Posey; Monte Westerfield; John Postlethwait; Philip Hieter; Kym M Boycott; Philippe M Campeau; Hugo J Bellen
Journal:  Genetics       Date:  2017-09       Impact factor: 4.562

9.  The Monarch Initiative in 2019: an integrative data and analytic platform connecting phenotypes to genotypes across species.

Authors:  Kent A Shefchek; Nomi L Harris; Michael Gargano; Nicolas Matentzoglu; Deepak Unni; Matthew Brush; Daniel Keith; Tom Conlin; Nicole Vasilevsky; Xingmin Aaron Zhang; James P Balhoff; Larry Babb; Susan M Bello; Hannah Blau; Yvonne Bradford; Seth Carbon; Leigh Carmody; Lauren E Chan; Valentina Cipriani; Alayne Cuzick; Maria Della Rocca; Nathan Dunn; Shahim Essaid; Petra Fey; Chris Grove; Jean-Phillipe Gourdine; Ada Hamosh; Midori Harris; Ingo Helbig; Maureen Hoatlin; Marcin Joachimiak; Simon Jupp; Kenneth B Lett; Suzanna E Lewis; Craig McNamara; Zoë M Pendlington; Clare Pilgrim; Tim Putman; Vida Ravanmehr; Justin Reese; Erin Riggs; Sofia Robb; Paola Roncaglia; James Seager; Erik Segerdell; Morgan Similuk; Andrea L Storm; Courtney Thaxon; Anne Thessen; Julius O B Jacobsen; Julie A McMurry; Tudor Groza; Sebastian Köhler; Damian Smedley; Peter N Robinson; Christopher J Mungall; Melissa A Haendel; Monica C Munoz-Torres; David Osumi-Sutherland
Journal:  Nucleic Acids Res       Date:  2020-01-08       Impact factor: 16.971

10.  Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium.

Authors:  Megan L Grove; Bing Yu; Barbara J Cochran; Talin Haritunians; Joshua C Bis; Kent D Taylor; Mark Hansen; Ingrid B Borecki; L Adrienne Cupples; Myriam Fornage; Vilmundur Gudnason; Tamara B Harris; Sekar Kathiresan; Robert Kraaij; Lenore J Launer; Daniel Levy; Yongmei Liu; Thomas Mosley; Gina M Peloso; Bruce M Psaty; Stephen S Rich; Fernando Rivadeneira; David S Siscovick; Albert V Smith; Andre Uitterlinden; Cornelia M van Duijn; James G Wilson; Christopher J O'Donnell; Jerome I Rotter; Eric Boerwinkle
Journal:  PLoS One       Date:  2013-07-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.